Nuveen
AXGN icon

Nuveen’s Axogen AXGN Stock Holding History

Nuveen’s Portfolio AXGN Stock Details AXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.2M Buy
545,892
+436,951
+401% +$17.6M 0.01% 1117
2026
Q1 		$3.61M Sell
108,941
-12,022
-10% -$391K ﹤0.01% 2030
2025
Q4 		$3.96M Buy
120,963
+30,554
+34% +$751K ﹤0.01% 2013
2025
Q3 		$1.61M Sell
90,409
-42,610
-32% -$618K ﹤0.01% 2386
2025
Q2 		$1.44M Sell
133,019
-173,367
-57% -$2.27M ﹤0.01% 2439
2025
Q1 		$5.67M Buy
306,386
+179,310
+141% +$3.24M ﹤0.01% 1857
2024
Q4 		$2.09M Sell
127,076
-21,370
-14% -$303K ﹤0.01% 2366
2024
Q3 		$2.08M Sell
148,446
-204,690
-58% -$2.26M ﹤0.01% 2389
2024
Q2 		$2.56M Hold
353,136
– – ﹤0.01% 2263
2024
Q1 		$2.85M Hold
353,136
– – ﹤0.01% 2238
2023
Q4 		$2.41M Buy
353,136
+165,310
+88% +$919K ﹤0.01% 2324
2023
Q3 		$939K Buy
187,826
+2,483
+1% +$17.2K ﹤0.01% 2600
2023
Q2 		$1.69M Buy
185,343
+3,489
+2% +$32.5K ﹤0.01% 2424
2023
Q1 		$1.72M Buy
181,854
+7,965
+5% +$72.8K ﹤0.01% 2398
2022
Q4 		$1.74M Buy
173,889
+64,963
+60% +$721K ﹤0.01% 2452
2022
Q3 		$1.3M Sell
108,926
-8,907
-8% -$89.1K ﹤0.01% 2619
2022
Q2 		$965K Sell
117,833
-43,262
-27% -$370K ﹤0.01% 2791
2022
Q1 		$1.37M Buy
161,095
+7,770
+5% +$67.1K ﹤0.01% 2684
2021
Q4 		$1.44M Sell
153,325
-7,613
-5% -$91.3K ﹤0.01% 2719
2021
Q3 		$2.54M Sell
160,938
-52,399
-25% -$941K ﹤0.01% 2558
2021
Q2 		$4.61M Buy
213,337
+63,494
+42% +$1.28M ﹤0.01% 2297
2021
Q1 		$3.04M Buy
149,843
+5,233
+4% +$103K ﹤0.01% 2413
2020
Q4 		$2.59M Buy
144,610
+466
+0.3% +$6.84K ﹤0.01% 2381
2020
Q3 		$1.68M Buy
144,144
+4,488
+3% +$52.1K ﹤0.01% 2468
2020
Q2 		$1.29M Sell
139,656
-15,016
-10% -$135K ﹤0.01% 2512
2020
Q1 		$1.61M Sell
154,672
-357
-0.2% -$4.54K ﹤0.01% 2292
2019
Q4 		$2.77M Sell
155,029
-4,986
-3% -$73.7K ﹤0.01% 2285
2019
Q3 		$2M Buy
160,015
+2,787
+2% +$45.9K ﹤0.01% 2400
2019
Q2 		$3.11M Buy
+157,228
New +$3.36M ﹤0.01% 2230

Other funds holding AXGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Nuveen's AXGN Position: Q2 2026 in Review

Nuveen increased its Axogen (AXGN) stake by 401% in Q2 2026, buying an estimated $17.6M and bringing the position to 545,892 shares worth $25.2M. The position accounts for 0.01% of the portfolio, ranked #1117.

Nuveen first reported a position in AXGN in Q2 2019 and has held it in 29 quarters since. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Nuveen held 545,892 shares of Axogen worth $25.2M as of Q2 2026.
  • Nuveen bought 436,951 Axogen shares in Q2 2026, an estimated $17.6M.
  • Axogen made up 0.01% of Nuveen's portfolio in Q2 2026, its #1117 holding.
  • Nuveen first reported a position in Axogen in Q2 2019 and has held it in 29 quarters since.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.